Two Sigma Advisers’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $217K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $8.51M | Sell |
|
|||||
|
2023
Q1 | $26.2M | Sell |
|
|||||
|
2022
Q4 | $33.7M | Buy |
|
|||||
|
2022
Q3 | $20.6M | Buy |
|
|||||
|
2022
Q2 | $7.55M | Sell |
|
|||||
|
2022
Q1 | $10.2M | Buy |
|
|||||
|
2021
Q4 | $6.03M | Buy |
|
|||||
|
2021
Q3 | $2.15M | Sell |
|
|||||
|
2021
Q2 | $3.97M | Sell |
|
|||||
|
2021
Q1 | $4.13M | Buy |
|
|||||
|
2020
Q4 | $2.43M | Sell |
|
|||||
|
2020
Q3 | $2.18M | Sell |
|
|||||
|
2020
Q2 | $5.06M | Buy |
|
|||||
|
2020
Q1 | $1.7M | Sell |
|
|||||
|
2019
Q4 | $1.71M | Buy |
|
|||||
|
2019
Q3 | $68K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $19K | Sell |
|
|||||
|
2018
Q3 | $220K | Sell |
|
|||||
|
2018
Q2 | $270K | Buy |
|
|||||
|
2018
Q1 | $158K | Sell |
|
|||||
|
2017
Q4 | $305K | Buy |
|